Chronic Spontaneous Urticaria August 22, 2025 By Rebecca Dotterweich A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines (RECLAIM) More Details Filed Under: More from Department of Dermatology Dermatopathology Fellowship Protected: Toronto GEM Meeting: Jul 27–29, 2009 Residency Training Program